The Immuno Bill is a Reality! Guidance for the New "Medicare Part B-ID"
The Immuno Bill is a Reality! Guidance for the New "Medicare Part B-ID"
Understand the significance of the bill, and identify the target population for the new benefit and logistics and requirements of the coverage.
- 2:00 PM - 3:00 PM EDT
- Virtual, as part of AST's T3 webinar series.
Objectives:
After participating in this webinar, the attendee will be able to:
- Understand the significance of the moment, including the experience of testifying before Congress, questions asked, and concerns revealed.
- Identify the target population for the new benefit, strategies to identify eligible patients, and how to enroll patients.
- Understand logistics of the coverage, requirements of the prescription, and how the coverage works.
A 1-page, summary handout on Lifelong Immunosuppressive Drug Coverage for Kidney Transplant is available with the on-demand recording.
Speakers:
- Matthew Cooper, MD, FAST • Director, Kidney and Pancreas Transplantation, MedStar Georgetown Transplant Institute, Washington, DC
- Nancy Edgington, LCSW III, CCTSW • Lead Kidney Transplant Social Worker, Yale New Haven Hospital, New Haven, CT
- Jennifer McDermott, PharmD, BCTXP, BCPS • Clinical Pharmacy Specialist, Solid Organ Transplant, Spectrum Health, Grand Rapids, MI
Moderator:
- Lisa Potter, PharmD, BCTXP, FCCP, FAST • Clinical Coordinator, Organ Transplant, University of Chicago Medicine, Chicago, IL
- - - - -
This topic was suggested by the AST Education Committee for inclusion in the 2022-2023 T3 webinar series. The Committee would like to thank the leadership of AST's Transplant Pharmacy Community of Practice (TxPharm COP) for their feedback on session speakers. Learn more about AST's COPs at www.www.myast.org/cops.
Advertisements
This content was developed independently by AST and supported by a financial contribution from
